Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
We welcome Príncipe de Asturias University Hospital in Madrid, that has just joined the RESILIENCE project, together we will keep on working with the aim of helping people with cancer to live with a strong heart. The Príncipe de Asturias University Hospital is located in the city of Alcalá de Henares and since its inauguration […]
